Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ABDO, K.M.
Right arrow Articles by ABOU-DONIA, M.B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ABDO, K.M.
Right arrow Articles by ABOU-DONIA, M.B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1983 Oxford University Press

research-article

Heinz Body Production and Hematological Changes in the Hen After Administration of a Single Oral Dose of n-Butyl Mercaptan and n-Butyl Disulfide

K.M. ABDO1, P.R. TIMMONS2, D.G. GRAHAM3 and M.B. ABOU-DONIA4

1National Toxicology Program, National Institute of Environmental Health Sciences P.O. Box 12233, Research Triangle Park, NC 27709 2Union Carbide, Agricultural Products P.O. Box 12014, Research Triangle Park, NC 27709 3Department of Pathology, Duke University Medical Center Durham, NC 27710 4Department of Pharmacology Duke University Medical Center, Durham, NC 27710

Heinz Body Production and Hematological Changes in the Hen After Administration of a Single Oral Dose of n-Butyl Mercaptan and n-Butyl Disulfide. Abdo, K.M., Timmons, P.R., Graham, D.G. and Abou-Donia, M.B. (1983). Fundam. Appl. Toxicol. 3:69-74. n-Butyl mercaptan (nBM) is a breakdown product of S,S,S-tri-n-butyl phosphorotrithioate (DEF) and S,S,S-tri-n-butyl phosphoro-trithioite (merphos) in hens and in the environment. n-Butyl disulfide (nBD) is an oxidation product of nBM. A single 500 mg/kg dose of nBM and nBD was administered in gelatin capsules to groups of five 12-month old laying hens. A third group (five hens) was given gelatin capsules. One day after administration, the hens exhibited weakness which progressed to unsteadiness and inability to stand by the third day. These signs were accompanied by a pale comb 18–24 hr after dosing, which changed to dark color at 48 hr. Treated hens improved with time. Heinz bodies and extensive erythrocyte deformation and lysis were observed in blood smears taken from hens 24 and 48 hr after treatment. Hemoglobin concentration, packed cell volume, erythrocytes, and glucose-6-phosphate dehydrogenase activity were significantly lower than controls, while methemoglobin was significantly higher. As the clinical condition of these hens improved, these hematologic changes disappeared. nBM caused an initial increase in plasma butyrylcholinesterase activity which was dose-dependent and returned to normal by the end of the 28-day experiment. Also, brain acetylcholinesterase activity was not different from that of the control at termination.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.